Valproic acid, but not its non-teratogenic analogue 2-isopropylpentanoic acid, affects proliferation, viability and neuronal differentiation of the human teratocarcinoma cell line NTera-2.
The antiepileptic drug valproic acid (VPA) is an established human teratogen that affects neural development in human fetuses exposed to the drug during early pregnancy. The development of simple cell culture models that reflect normal neuronal development will be useful for the screening of neural developmental toxicity of new drugs and for the identification of the specific molecular targets for the teratogenic action. The present study tests a human NT2 cell line for its suitability to serve as such a model. Treatment with VPA, but not with its non-teratogenic-analogue, 2-isopropylpentanoic acid (IPPA), inhibited cell growth, had a cytotoxic effect and blocked retinoic acid-induced neuronal differentiation of NT2 cells. Differentiation was evaluated by immunostaining for neurofilament proteins, microtubule associated proteins-2 (MAP-2), tau and neural cell adhesion molecule, NCAM. However once differentiation had taken place, VPA did not revert this process, although it did affect neuronal aggregation and neurite fasciculation. These results suggest that the human NT2 cell line might be useful for identifying drugs affecting neuronal development in humans.
Skladchikova
G
G
Protein Laboratory, University of Copenhagen, Denmark.
Berezin
V
V
Bock
E
E
D000927:Anticonvulsants / Q000494:pharmacology*; D002449:Cell Aggregation / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D006801:Humans; D008938:Mitosis / Q000187:drug effects; D008970:Molecular Weight; D016501:Neurites / Q000187:drug effects; D009474:Neurons / Q000166:cytology / Q000187:drug effects*; D010421:Pentanoic Acids / Q000494:pharmacology*; D018243:Teratocarcinoma / Q000188:drug therapy* / Q000473:pathology; D013723:Teratogens / Q000494:pharmacology*; D014212:Tretinoin / Q000037:antagonists & inhibitors; D014635:Valproic Acid / Q000494:pharmacology*
D000927:Anticonvulsants; D010421:Pentanoic Acids; D013723:Teratogens; C113974:2-isopropylpentanoic acid; D014212:Tretinoin; D014635:Valproic Acid